project id: TCGA-CESC; case submitter id: TCGA-EK-A2RB; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.2; rna integrity number: 7.3; age at index: 48; days to birth: -17752; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1963; age at diagnosis: 17752; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 9.0; figo stage: Stage IVB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 169; initial weight: 70.0; oct embedded: false; preservation method: Unknown; sample id: 8254cf9e-5176-4649-b8f5-a6f61ead3cd6; sample submitter id: TCGA-EK-A2RB-01A; portion id: 72d2d43e-694c-477d-a35d-d761db34670c; portion submitter id: TCGA-EK-A2RB-01A-11; slide id: 45101b3c-e301-4bd3-b4ef-69428940c0d4; slide submitter id: TCGA-EK-A2RB-01A-01-TS1; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 1.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 84.0; percent tumor nuclei: 92.0; section location: TOP;